These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 25676051)
21. Membrane transporter engineering in industrial biotechnology and whole cell biocatalysis. Kell DB; Swainston N; Pir P; Oliver SG Trends Biotechnol; 2015 Apr; 33(4):237-46. PubMed ID: 25746161 [TBL] [Abstract][Full Text] [Related]
22. Can the natural diversity of quorum-sensing advance synthetic biology? Davis RM; Muller RY; Haynes KA Front Bioeng Biotechnol; 2015; 3():30. PubMed ID: 25806368 [TBL] [Abstract][Full Text] [Related]
23. A method for multiplex gene synthesis employing error correction based on expression. Hsiau TH; Sukovich D; Elms P; Prince RN; Strittmatter T; Ruan P; Curry B; Anderson P; Sampson J; Anderson JC PLoS One; 2015; 10(3):e0119927. PubMed ID: 25790188 [TBL] [Abstract][Full Text] [Related]
24. A tRNA-guided research journey from synthetic chemistry to synthetic biology. Soll D RNA; 2015 Apr; 21(4):742-4. PubMed ID: 25780217 [No Abstract] [Full Text] [Related]
25. Heterologous production of caffeic acid from tyrosine in Escherichia coli. Rodrigues JL; Araújo RG; Prather KL; Kluskens LD; Rodrigues LR Enzyme Microb Technol; 2015 Apr; 71():36-44. PubMed ID: 25765308 [TBL] [Abstract][Full Text] [Related]
26. [Application and potential of genome engineering by artificial enzymes]. Nomura W Yakugaku Zasshi; 2015; 135(3):405-14. PubMed ID: 25759050 [TBL] [Abstract][Full Text] [Related]
27. Fluoro amino acids: a rarity in nature, yet a prospect for protein engineering. Odar C; Winkler M; Wiltschi B Biotechnol J; 2015 Mar; 10(3):427-46. PubMed ID: 25728393 [TBL] [Abstract][Full Text] [Related]
28. Process for Assembly and Transformation into Saccharomyces cerevisiae of a Synthetic Yeast Artificial Chromosome Containing a Multigene Cassette to Express Enzymes That Enhance Xylose Utilization Designed for an Automated Platform. Hughes SR; Cox EJ; Bang SS; Pinkelman RJ; López-Núñez JC; Saha BC; Qureshi N; Gibbons WR; Fry MR; Moser BR; Bischoff KM; Liu S; Sterner DE; Butt TR; Riedmuller SB; Jones MA; Riaño-Herrera NM J Lab Autom; 2015 Dec; 20(6):621-35. PubMed ID: 25720598 [TBL] [Abstract][Full Text] [Related]
30. Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders. Heng BC; Aubel D; Fussenegger M Curr Opin Biotechnol; 2015 Dec; 35():37-45. PubMed ID: 25679308 [TBL] [Abstract][Full Text] [Related]
31. A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. Druedahl LC; Almarsdóttir AB; Kälvemark Sporrong S; De Bruin ML; Hoogland H; Minssen T; van de Weert M; Kesselheim AS; Sarpatwari A Nat Biotechnol; 2020 Nov; 38(11):1253-1256. PubMed ID: 33144720 [No Abstract] [Full Text] [Related]
32. Responsibility and intellectual property in synthetic biology: A proposal for using Responsible Research and Innovation as a basic framework for intellectual property decisions in synthetic biology. König H; Dorado-Morales P; Porcar M EMBO Rep; 2015 Sep; 16(9):1055-9. PubMed ID: 26268525 [No Abstract] [Full Text] [Related]
34. Realizing the potential of synthetic biology. Church GM; Elowitz MB; Smolke CD; Voigt CA; Weiss R Nat Rev Mol Cell Biol; 2014 Apr; 15(4):289-94. PubMed ID: 24622617 [TBL] [Abstract][Full Text] [Related]
35. Synthetic biology and intellectual property rights: six recommendations. Minssen T; Rutz B; van Zimmeren E Biotechnol J; 2015 Feb; 10(2):236-41. PubMed ID: 25676051 [TBL] [Abstract][Full Text] [Related]
36. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications. van Zimmeren E; Rutz B; Minssen T Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844 [TBL] [Abstract][Full Text] [Related]
37. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health. Schneider I Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920 [TBL] [Abstract][Full Text] [Related]